BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 14644131)

  • 1. LAG-3: a regulator of T-cell and DC responses and its use in therapeutic vaccination.
    Triebel F
    Trends Immunol; 2003 Dec; 24(12):619-22. PubMed ID: 14644131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Lymphocytes infiltrating various tumour types express the MHC class II ligand lymphocyte activation gene-3 (LAG-3): role of LAG-3/MHC class II interactions in cell-cell contacts.
    Demeure CE; Wolfers J; Martin-Garcia N; Gaulard P; Triebel F
    Eur J Cancer; 2001 Sep; 37(13):1709-18. PubMed ID: 11527700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223).
    Andreae S; Piras F; Burdin N; Triebel F
    J Immunol; 2002 Apr; 168(8):3874-80. PubMed ID: 11937541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells.
    Buisson S; Triebel F
    Vaccine; 2003 Feb; 21(9-10):862-8. PubMed ID: 12547595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors.
    Buisson S; Triebel F
    Immunology; 2005 Mar; 114(3):369-74. PubMed ID: 15720438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-12 production by monocytes and dendritic cells.
    Avice MN; Sarfati M; Triebel F; Delespesse G; Demeure CE
    J Immunol; 1999 Mar; 162(5):2748-53. PubMed ID: 10072520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses.
    Prigent P; El Mir S; Dréano M; Triebel F
    Eur J Immunol; 1999 Dec; 29(12):3867-76. PubMed ID: 10601994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223).
    Andreae S; Buisson S; Triebel F
    Blood; 2003 Sep; 102(6):2130-7. PubMed ID: 12775570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells.
    Workman CJ; Vignali DA
    Eur J Immunol; 2003 Apr; 33(4):970-9. PubMed ID: 12672063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAG-3 regulates plasmacytoid dendritic cell homeostasis.
    Workman CJ; Wang Y; El Kasmi KC; Pardoll DM; Murray PJ; Drake CG; Vignali DA
    J Immunol; 2009 Feb; 182(4):1885-91. PubMed ID: 19201841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte-activation gene 3/major histocompatibility complex class II interaction modulates the antigenic response of CD4+ T lymphocytes.
    Huard B; Tournier M; Hercend T; Triebel F; Faure F
    Eur J Immunol; 1994 Dec; 24(12):3216-21. PubMed ID: 7805750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble human lymphocyte activation gene-3 modulates allospecific T cell responses.
    Subramanyam M; Wands G; Nabioullin R; Tepper MA
    Int Immunol; 1998 May; 10(5):679-89. PubMed ID: 9645616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
    Hannier S; Triebel F
    Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL10- and IL35-Secreting MutuDC Lines Act in Cooperation to Inhibit Memory T Cell Activation Through LAG-3 Expression.
    Koga MM; Engel A; Pigni M; Lavanchy C; Stevanin M; Laversenne V; Schneider BL; Acha-Orbea H
    Front Immunol; 2021; 12():607315. PubMed ID: 33679743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble pig lymphocyte activation gene-3 (LAG-3; CD223) inhibits human-to-pig xenogeneic mixed lymphocyte reaction.
    Kim SS; Byun HJ; Kim SH; Lee HH; Lee SJ; Kim SJ; Park CG; Chun T
    Biotechnol Lett; 2010 Feb; 32(2):203-8. PubMed ID: 19834647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: molecular analysis of the negative regulatory function of lymphocyte activation gene-3.
    Workman CJ; Dugger KJ; Vignali DA
    J Immunol; 2002 Nov; 169(10):5392-5. PubMed ID: 12421911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells.
    Maçon-Lemaître L; Triebel F
    Immunology; 2005 Jun; 115(2):170-8. PubMed ID: 15885122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell major histocompatibility complex class II molecules down-regulate CD4+ T cell clone responses following LAG-3 binding.
    Huard B; Prigent P; Pagès F; Bruniquel D; Triebel F
    Eur J Immunol; 1996 May; 26(5):1180-6. PubMed ID: 8647185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anergic T cells inhibit the antigen-presenting function of dendritic cells.
    Vendetti S; Chai JG; Dyson J; Simpson E; Lombardi G; Lechler R
    J Immunol; 2000 Aug; 165(3):1175-81. PubMed ID: 10903714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.